AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Top 20%
#1087 out of 5511 analysts
Average Return
+8.75%
Win Rate
58%23 out of 40
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +86.98% | $138.00 | $258.03 | 2025-07-28 - 2026-07-27 | Buy |
Natera IncNTRA | +80.59% | $194.24 | $350.78 | 2026-05-08 - 2026-09-15 | Buy |
Natera IncNTRA | +75.77% | $199.57 | $350.78 | 2025-11-07 - 2026-09-15 | Buy |
Natera IncNTRA | +68.61% | $208.04 | $350.78 | 2026-02-27 - 2026-09-15 | Buy |
Guardant Health IncGH | +60.58% | $63.44 | $101.87 | 2025-10-07 - 2026-01-05 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Minimed Group IncMMED | 2 | Buy | $27.00 | +22.67% | Maintains | 14 days ago |
Natera IncNTRA | 6 | Buy | $360.00 | +2.63% | Maintains | a month ago |
Inspire Medical Systems IncINSP | 6 | Hold | $54.00 | -27.61% | Maintains | a month ago |
Rambus IncRMBS | 5 | Buy | $160.00 | +92.52% | Maintains | 2 months ago |
West Pharmaceutical Services IncWST | 6 | Buy | $425.00 | +16.44% | Maintains | 2 months ago |
Transmedics Group IncTMDX | 4 | Buy | $90.00 | +2.17% | Maintains | 2 months ago |
Repligen CorpRGEN | 7 | Buy | $160.00 | -8.43% | Maintains | 2 months ago |
Insulet CorpPODD | 4 | Buy | $180.00 | +29.27% | Maintains | 2 months ago |
Guardant Health IncGH | 6 | Hold | $95.00 | -45.92% | Maintains | 4 months ago |
Bio Techne CorpTECH | 6 | Hold | $50.00 | -30.88% | Maintains | 4 months ago |
Dexcom IncDXCM | 1 | Hold | $68.00 | -21.34% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.